NOD/SCID mice were subcutaneously injected with either control CHL−1 melanoma cells or Nudt2 knocked down IVIS; the analysis revealed a significant difference in tumor growth between the control and Nudt2 knockdown groups (p = 0.032; Figure 3D,F). The gene discussed is NUDT2; the disease is neoplasm.